Excellent discussion from Natasha Leighl contextualising Saffron study. MET amplification defined by previous Savannah study. Is IHC enough - yes!Control arm performs as expected, but note that MET is a poor prognostic marker
But less than a third have MET 3+.
#ESMO26 #LCSM